Evonik stock: BASF ends takeover bid after two rejections
Published on 11/20/2026 at 17:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points for investors
- BASF ended its effort to acquire Evonik on November 19 after Evonik rejected two non-binding all-cash offers.
- Evonik stock traded 0.88 percent above the Xetra close of November 19 during Friday trading.
- The failed approach leaves Evonik's standalone strategy at the center of the valuation debate.
Evonik stock traded at 18.42 euros on Lang & Schwarz at 17:14 CET on Friday, November 20, 16.57 percent below the 22.08 euros recorded in our November 17 report. On Xetra, the shares stood at 18.41 euros, 0.88 percent above the Xetra close of Thursday, November 19.
BASF ends Evonik approach
BASF said on November 19 that it was ending its effort to acquire Evonik after Evonik rejected two non-binding all-cash offers. The announcement came from BASF in a November 19 news release.
BASF said it had been prepared to consider a further moderate increase, but concluded that Evonik's standalone prospects and associated risks did not justify a higher valuation. BASF's latest offer was 24 euros per share, according to the release.
Standalone strategy in focus
The end of the approach removes the immediate prospect of a transaction at the terms described by BASF. For Evonik investors, the company's independent strategy and its ability to improve operating performance remain central to the valuation discussion.
The movement since the November 17 report is separate from Friday's Xetra session. The current Lang & Schwarz quote was 18.42 euros at 17:14 CET, while the Xetra close from the previous session was 18.25 euros.
Evonik Industries AG
- ISIN: DE000EVNK013
- Ticker: EVK.DE
- Trading venue: Lang & Schwarz
- Price: 18.42 euros at 17:14 CET on November 20, 2026
- Change since November 17 report: -16.57 percent
- Xetra close: 18.25 euros on November 19, 2026
- Xetra session change: +0.88 percent on November 20, 2026
Broader market conditions remain relevant for chemical shares; see Current market reports.
More company developments are collected in More news and analyses on Evonik stock.
